Related Experiment Video
Updated: Mar 1, 2026
03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
Determination of the Mechanisms that Cause Sarcopenia through cDNA Microarray.
1Hae Young Chung, Interdisciplinary Research Program of Bioinformatics and Longevity Science, Pusan National University, Kumjeong-Gu, Busan 46251, Republic of Korea Tel: +82-51-510-2814; Fax: +82-51-510-2821;
The Journal of Frailty & Aging
|May 31, 2017
Summary
Sarcopenia, an age-related muscle decline, is linked to mitochondrial dysfunction and altered lipid metabolism. Identifying these factors may lead to new therapeutic targets for this common aging disease.
Area of Science:
- Gerontology
- Molecular Biology
- Bioinformatics
Background:
- Sarcopenia, the age-related loss of skeletal muscle mass and function, significantly impacts quality of life.
- The global increase in the aging population heightens the urgency for preventing age-related diseases like sarcopenia.
Purpose of the Study:
- To identify potential therapeutic targets for sarcopenia.
- To investigate the molecular mechanisms underlying sarcopenia.
Main Methods:
- Bioinformatics approach combining cDNA microarray analysis.
- Protein-protein interaction prediction analysis.
- Differential gene expression analysis in sarcopenia patients over 60 years of age.
Main Results:
- Identified 673 differentially expressed genes (128 upregulated, 545 downregulated).
- Upregulated genes are linked to metabolic processes, including the PPAR signaling pathway (e.g., FABP4, PLIN1, ADIPOQ) and fatty acid/lipid metabolism.
- Downregulated genes were found in the mitochondrial matrix; key autophagy-related molecules (MAP1LC3B, HSP90AB1) were identified via network analysis.
Conclusions:
- Mitochondrial dysfunction is implicated in sarcopenia.
- Altered lipid metabolism is associated with sarcopenia.
- Bioinformatic analysis revealed potential molecular targets for sarcopenia intervention.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:22PI3K/mTOR/AKT Signaling Pathway
5.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.9K